Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.297 USD | -11.96% |
|
-5.49% | +53.10% |
Sales 2024 * | 10.6M 11.56M 891M | Sales 2025 * | 6.95M 7.58M 584M | Capitalization | 34.79M 37.93M 2.92B |
---|---|---|---|---|---|
Net income 2024 * | -11M -11.99M -925M | Net income 2025 * | -17M -18.54M -1.43B | EV / Sales 2024 * | 4.89 x |
Net Debt 2024 * | 17M 18.54M 1.43B | Net Debt 2025 * | 14M 15.26M 1.18B | EV / Sales 2025 * | 7.02 x |
P/E ratio 2024 * |
-3.19
x | P/E ratio 2025 * |
-2.11
x | Employees | 76 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.05% |
Latest transcript on Medigene AG
1 day | -11.96% | ||
1 week | -5.49% | ||
Current month | -5.49% | ||
1 month | -5.49% | ||
3 months | -5.49% | ||
6 months | +53.10% | ||
Current year | +53.10% |
![Extreme 1.76](/images/extremecours_fleche.png)
![Extreme 1.5](/images/extremecours_fleche.png)
![Extreme 1.5](/images/extremecours_fleche.png)
![Extreme 1.5](/images/extremecours_fleche.png)
![Extreme 1.5](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Selwyn Ho
CEO | Chief Executive Officer | 53 | 24/07/22 |
Dolores Schendel
CTO | Chief Tech/Sci/R&D Officer | - | 30/04/14 |
Pamela Keck
IRC | Investor Relations Contact | - | 31/01/23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 11/08/16 | |
Frank Mathias
BRD | Director/Board Member | 62 | 14/05/18 |
Anthony Man
BRD | Director/Board Member | 68 | 15/12/20 |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.17% | 126B | |
+24.67% | 118B | |
+25.44% | 27.87B | |
-17.74% | 20.95B | |
-15.17% | 16.92B | |
-15.21% | 16.18B | |
+11.91% | 14.84B | |
-47.10% | 14.79B | |
+54.50% | 14.08B |
- Stock Market
- Equities
- MDG1 Stock
- MDGEF Stock